The United States is a major contributor to the Osteopontin ELISA Kit Market, driven by its advanced biomedical research ecosystem, strong pharmaceutical and biotechnology industries, and growing focus on biomarker-based diagnostics. Increasing investments in oncology research, precision medicine, and chronic disease studies continue to support the adoption of osteopontin ELISA kits across...